Living as an Acute Lymphocytic Leukemia (ALL) Survivor

Living as an Acute Lymphocytic Leukemia (ALL) Survivor

Retrieved February This information is particularly valuable for classification and can in part explain different prognosis of these groups. Checks will take place every two or three months for the first year, gradually becoming less frequent. The sequencing results and clonality analyses suggest that relapse of patient D directly evolved from the leukemic clone at diagnosis which survived chemotherapy.

The most common effects include nausea and vomiting, hair loss, reduced resistance to infection, bruising and bleeding, tiredness and diarrhoea.

Namespaces Article Talk. Monosomy Turner syndrome 45,X.

Coping with Treatment. Search our clinical trials database for all cancer trials and studies recruiting in the UK. Several characteristic genetic changes lead to the creation of a leukemic lymphoblast. October Healthy behaviors such as not smoking, eating well, getting regular physical activity, and staying at a healthy weight might help, but no one knows for sure.

Acute lymphoblastic leukemia

Use the menu to see other pages. In general, cancer in children is uncommon. If ALL does relapse, it is usually while a person is still being treated or shortly after they've finished treatment.

Latest Research. Nelson Textbook of Pediatrics 19th ed. Part III. Idiopathic Juvenile idiopathic arthritis. The treatments used in ALL often cause side effects. Treatment overview In general, cancer in children is uncommon. If you have or had ALL, you probably want to know if there are things you can do to reduce your risk of the leukemia progressing or coming back , such as exercising, eating a certain type of diet, or taking nutritional supplements.

Mutational profiling of acute lymphoblastic leukemia with testicular relapse

Several genetic syndrome also carry increased risk of ALL. Specialty Hematology , oncology Symptoms Feeling tired, pale color, fever, easy bleeding or bruising, bone pain, enlarged lymph nodes [1] Complications Infection , tumor lysis syndrome [2] [3] Usual onset 2—5 years old [4] Types B-cell ALL , T-cell ALL [2] Causes Usually unknown [5] Risk factors Identical twin with ALL, Down syndrome , Fanconi anemia , ataxia telangiectasia , Klinefelter syndrome , high birth weight , significant radiation exposure [6] [5] [1] Diagnostic method Blood tests and bone marrow examination [3] Differential diagnosis Infectious mononucleosis , acute myeloid leukemia , lymphoblastic lymphoma , aplastic anemia [3] Treatment Chemotherapy , stem cell transplantation , radiation therapy , targeted therapy [1] Prognosis Children: Related research Reducing setbacks by tailoring indi To take advantage of these newer treatments, it is best that children with cancer be treated at a cancer center with access to specialists in pediatric cancer.

Chemotherapy is the primary treatment for ALL. Typically, people who experience a relapse in their ALL after initial treatment have a poorer prognosis than those who remain in complete remission after induction therapy.

Central nervous system CNS directed therapy.